Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Banks for High Fixed Store Rates: Amplify Your Reserve funds - 2Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
- 37 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Far reaching Guide
- 4Flourishing in Retirement: Individual Accounts of Post-Vocation Satisfaction
- 5FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- Journey Lines for Each Explorer: Track down Your Ideal Journey
- Exploring the Gig Economy: Examples from Consultants
- New ‘Cloud-9’ object could reveal the secrets of dark matter
- Four Dead in Last Month From Animal Attacks in Nepal
- IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports
- Haifa refinery said hit in latest Iranian missile barrage
- A Manual for Pick Viable Psychological well-being Backing Administrations In 2024
- 5 Christmas movies to stream for less with this Paramount+ Black Friday deal
- Want to make America healthy again? Stop fueling climate change
